Philogen grants Pfizer exclusive, worldwide rights to Dekavil, an immunocytokine consisting of a vascular targeting antibody fused to the anti-inflammatory cytokine IL-10

Philogen S.p.A.

Italy / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Pfizer Inc.

U.S. / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced